Seoul St. Mary's Hospital

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Study to Evaluate Clinical Efficacy and Safety of Bio Mineral Toothpaste in Patients With Mild Periodontitis

Phase 4

Completed

Conditions: Periodontitis

Interventions: Other: Perio Total Care toothpaste
Other: Bio Mineral toothpaste

First Posted Date: 2012-03-08

Last Posted Date: 2013-02-06

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 60

Registration Number: NCT01548469

Locations: 🇰🇷
Seoul St.Mary's Hospital, Seocho-Gu, Seoul, Korea, Republic of

Study to Evaluate Clinical Efficacy and Safety of "Medifoam H" in Wound Healing

Phase 4

Completed

Conditions: Trauma

Interventions: Device: Medifoam H dressing
Device: Duoderm THIN dressing

First Posted Date: 2012-03-08

Last Posted Date: 2013-02-06

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 66

Registration Number: NCT01548443

Locations: 🇰🇷
Seoul St. Mary's Hospital, Seoul, Korea, Republic of

Acute Changes in Intraocular Cytokines After Intravitreal Bevacizumab

Not Applicable

Conditions: Complications of Diabetes Mellitus

Interventions: Drug: Intravitreal Avastin injection

First Posted Date: 2011-09-23

Last Posted Date: 2011-09-23

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 28

Registration Number: NCT01439178

Locations: 🇰🇷
Seoul Saint Mary's hospital, Seoul, Korea, Republic of

Effect of Intravitreal Bevacizumab on Focal Edema With Hard Exudates Secondary to Diabetic Retinopathy

Not Applicable

Conditions: Diabetes Complications

Interventions: Drug: Avastin (bevacizumab)

First Posted Date: 2011-08-23

Last Posted Date: 2011-09-23

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 10

Registration Number: NCT01422018

Locations: 🇰🇷
Seoul St Mary's hospital, Seocho, Seoul, Korea, Republic of

Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH

Phase 4

Terminated

Conditions: NASH (Non-alcoholic Steato-hepatitis)

Interventions: Drug: Rosiglitazone
Drug: alpha-lipoic acid
Drug: Rosiglitazone/alpha-lipoic acid

First Posted Date: 2011-08-01

Last Posted Date: 2011-08-19

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 26

Registration Number: NCT01406704

Efficacy of Nilotinib Versus Imatinib in Ph+ CML in Early CP Who Have a Suboptimal Molecular Response to Imatinib

Phase 3

Conditions: Chronic Myeloid Leukemia

Interventions: Drug: Nilotinib, Imatinib

First Posted Date: 2011-07-22

Last Posted Date: 2014-01-13

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 100

Registration Number: NCT01400074

Locations: 🇰🇷
Seoul St. Mary's Hospital, Seoul, Korea, Republic of

Aqueous Humor Level of Cytokines in Polypoidal Choroidal Vasculopathy and Change of Cytokines After Photodynamic Therapy

Not Applicable

Conditions: Polypoidal Choroidal Vasculopathy

Interventions: Drug: ranibizumab(Lucentis), verteporfin(Visudyne)

First Posted Date: 2011-05-25

Last Posted Date: 2011-05-30

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 16

Registration Number: NCT01360151

Locations: 🇰🇷
Won Ki Lee, Seoul, Korea, Republic of

Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML

Phase 1

Conditions: Myelodysplastic Syndrome
Acute Myeloid Leukemia

Interventions: Drug: Decitabine

First Posted Date: 2011-01-17

Last Posted Date: 2015-11-20

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 19

Registration Number: NCT01277484

Locations: 🇰🇷
Seoul St. Mary's Hospital, Seoul, Korea, Republic of

A Study to Evaluate Pharmacokinetics of C3G and to Estimate Antioxidative Markers After Repeated Administration of Mulberry Fruit Extract

Not Applicable

Completed

Conditions: Oxidative Stress

Interventions: Other: Mulberry fruit extract

First Posted Date: 2010-10-29

Last Posted Date: 2010-12-14

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 12

Registration Number: NCT01230268

Locations: 🇰🇷
Seoul St.Mary's Hospital, Seoul, Korea, Republic of

A Study to Evaluate Pharmacokinetics of C3G and to Estimate Antioxidative Markers After Repeated Administration of Black Bean Seed Coat Extract

Not Applicable

Completed

Conditions: Oxidative Stress

Interventions: Other: Black bean seed coat extract

First Posted Date: 2010-10-29

Last Posted Date: 2010-12-14

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 12

Registration Number: NCT01230281

Locations: 🇰🇷
Seoul St.Mary's Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy